106418-67-1

Basic information

• Product Name: 1-BROMO-4-DECYLBENZENE
• Synonyms: 4-DECYLBROMOBENZENE;4-N-DECYLBROMOBENZENE;1-BROMO-4-DECYLBENZENE;1-BROMO-4-N-DECYLBENZENE;4-Bromo-1-decylbenzene;4-Decyl-1-bromobenzene;Benzene,1-bromo-4-decyl-
• CAS NO: 106418-67-1
• Molecular Formula: C₁₆H₂₅Br
• Molecular Weight: 297.27
• Product Categories: 4-Alkylbromobenzenes (Building Blocks for Liquid Crystals);Building Blocks for Liquid Crystals;Functional Materials
• Mol File: 106418-67-1.mol
• Article Data: 14

Chemical Properties

• Boiling Point: 346℃
• Flash Point: 206℃
• Appearance: Colorless to pale yellow/Liquid
• Density: 1.099
• Vapor Pressure: 0.000119mmHg at 25°C
• Refractive Index: 1.5110
• Storage Temp.: Sealed in dry,Room Temperature
• CAS DataBase Reference: 1-BROMO-4-DECYLBENZENE(CAS DataBase Reference)
• NIST Chemistry Reference: 1-BROMO-4-DECYLBENZENE(106418-67-1)
• EPA Substance Registry System: 1-BROMO-4-DECYLBENZENE(106418-67-1)

Safety Data

• Hazardous Substances Data: 106418-67-1(Hazardous Substances Data)

Usage

General Description

1-Bromo-4-decylbenzene is a chemical compound with the molecular formula C16H25Br. It is a brominated derivative of decylbenzene, which is a hydrocarbon with a 10-carbon alkyl chain attached to a benzene ring. 1-Bromo-4-decylbenzene is widely used in organic synthesis and as a building block in the production of various compounds. It is also used as an intermediate in the manufacturing of pharmaceuticals and agrochemicals. This chemical is a colorless to light yellow liquid and is considered to be a hazardous substance, as it can cause irritation to the skin, eyes, and respiratory system upon exposure. Proper safety precautions should be taken when handling and using 1-Bromo-4-decylbenzene to prevent any potential health risks.

InChI:InChI=1/C16H25Br/c1-2-3-4-5-6-7-8-9-10-15-11-13-16(17)14-12-15/h11-14H,2-10H2,1H3

Upstream product

• 104-72-3 decylbenzene 
• 134443-99-5 1-(4-bromophenyl)decan-1-one 
• 112-29-8 1-bromo dodecane 
• 108-90-7 chlorobenzene 
• 37529-30-9 4-n-decylaniline 
• 30089-00-0 9-octyl-9-bora-bicyclo[3.3.1]nonane 
• 1746-28-7 1-bromo-4-(2-bromoethyl)benzene 
• 111-66-0 oct-1-ene 
• 2016-57-1 1-aminodecane 
• 5467-74-3 4-Bromophenylboronic acid 
• 108-86-1 bromobenzene 
• 7758-89-6 copper(I) chloride 
• 106-37-6 1.4-dibromobenzene 
• 112-13-0 n-decanoyl chloride 

Downstream Products

• 38300-04-8 4-decylbenzoic acid 
• 170981-25-6 (4-decylphenyl)boronic acid 
• 126708-45-0 1-decyl-4-ethynylbenzene 
• 106418-63-7 2--2-(chloromethyl)oxirane 
• 106418-48-8 sym-hydroxy-16-crown-5 
• 1246263-85-3 4,8-bis(4-decylphenylethynyl)benzo[1,2-b:4,5-b']dithiophene 
• 1246263-87-5 2,6-dibromo-4,8-bis(4-decylphenylethynyl)benzo-[1,2-b:4,5-b']dithiophene 
• 744246-56-8 (2-(4-decylphenyl)ethynyl)trimethylsilane 
• 93972-02-2 4-n-decylbiphenyl 
• 1398398-07-6 2-(4-decylphenyl)-4,4,5,5-tetramethyl-[1,3,2]dioxaborolane 

Relevant articles and documents

Synthesis of new iridium complexes and their electrophosphorescent properties in polymer light-emitting diodes

Several new iridium complexes with p-substituted 2-phenylpyridine (R-PPy) ligands have been synthesized and characterized. The complexes were incorporated into phosphorescent polymer light-emitting devices using soluble poly[1,4-bis(6′-cyano-6′-methylhept

Discovery of a novel activator of 5-lipoxygenase from an anacardic acid derived compound collection

Lipoxygenases (LOXs) and cyclooxygenases (COXs) metabolize poly-unsaturated fatty acids into inflammatory signaling molecules. Modulation of the activity of these enzymes may provide new approaches for therapy of inflammatory diseases. In this study, we screened novel anacardic acid derivatives as modulators of human 5-LOX and COX-2 activity. Interestingly, a novel salicylate derivative 23a was identified as a surprisingly potent activator of human 5-LOX. This compound showed both non-competitive activation towards the human 5-LOX activator adenosine triphosphate (ATP) and non-essential mixed type activation against the substrate linoleic acid, while having no effect on the conversion of the substrate arachidonic acid. The kinetic analysis demonstrated a non-essential activation of the linoleic acid conversion with a KA of 8.65 μM, αKA of 0.38 μM and a β value of 1.76. It is also of interest that a comparable derivative 23d showed a mixed type inhibition for linoleic acid conversion. These observations indicate the presence of an allosteric binding site in human 5-LOX distinct from the ATP binding site. The activatory and inhibitory behavior of 23a and 23d on the conversion of linoleic compared to arachidonic acid are rationalized by docking studies, which suggest that the activator 23a stabilizes linoleic acid binding, whereas the larger inhibitor 23d blocks the enzyme active site.

Solution processable symmetric 4-alkylethynylbenzene end-capped anthracene derivatives

New candidates composed of anthracene and 4-alkylethynylbenzene end-capped oligomers for OTFTs were synthesized under Sonogashira coupling reaction conditions. All oligomers were characterized by FT-IR, mass, UV-visible, and PL emission spectrum analyses, cyclic voltammetry (CV), differential scanning calorimetry (DSC), thermal gravimetric analysis (TGA), 1H-NMR, and 13C-NMR. Investigation of their physical properties showed that the oligomers had high oxidation potential and thermal stability. Thin films of DHPEAnt and DDPEAnt were characterized by spin coating them onto Si/SiO 2 to fabricate top-contact OTFTs. The devices prepared using DHPEAnt and DDPEAnt showed hole field-effect mobilities of 4.0 × 10-3 cm2/Vs and 2.0 × 10-3 cm2/Vs, respectively, for solution-processed OTFTs.